Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ilieva, Hristelina
NCT05597436: Intermediate-Sized Expanded Access Study	No Longer Available	N/A		US	Trehalose, SLS-005 Intravenous Trehalose Injection 90.5 mg/mL	Seelos Therapeutics, Inc., Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)	Amyotrophic Lateral Sclerosis
CNMAu8.EAP02, NCT05281484: Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and for ALS	Available	N/A		US	CNM-Au8, Nanocrystalline gold	Clene Nanomedicine	Amyotrophic Lateral Sclerosis